Last 1,230
Change Today +35.00 / 2.93%
Volume 3.1M
KAEF On Other Exchanges
Symbol
Exchange
Indonesia
As of 5:13 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

kimia farma persero tbk pt (KAEF) Snapshot

Open
$1,200
Previous Close
$1,195
Day High
$1,230
Day Low
$1,200
52 Week High
07/22/14 - $1,270
52 Week Low
09/5/13 - $420.00
Market Cap
6.8T
Average Volume 10 Days
6.7M
EPS TTM
$43.64
Shares Outstanding
5.6B
EX-Date
04/21/14
P/E TM
28.2x
Dividend
$9.66
Dividend Yield
0.79%
Current Stock Chart for KIMIA FARMA PERSERO TBK PT (KAEF)

Related News

No related news articles were found.

kimia farma persero tbk pt (KAEF) Related Businessweek News

No Related Businessweek News Found

kimia farma persero tbk pt (KAEF) Details

PT Kimia Farma (Persero) Tbk is engaged in producing, processing, marketing, and distributing chemical, pharmaceutical, biologic, and other materials required for the production of pharmaceutical, inventories, contraceptives, cosmetics, traditional medicines, medical equipment, food and beverages, and other products in Indonesia. The company operates through Manufacture, Distribution, Retail, and Others segments. It offers pharmaceutical finished products that include non betalactam, betalactam, antiretroviral, narcotic, herbal, hormone contraceptive, generic, oncology, ethical, and over the counter products, as well as intra uterine devices; and eye ointments, skin ointments/creams, quinine and quinine salts, castor oil and edible oils, cosmetics, iodine and iodine salts, and ferrous sulfate raw materials. The company offers its products in various dosage forms, such as tablets, coated tablets, capsules, oral powders, dry syrups, suspensions/syrups, creams, injections, soft capsules, suppository, granules, phytopharmaca, cosmetics powders, and liquid medicines for external use. In addition, it produces packing and indirect materials, machinery and equipment, and other supporting facilities related to pharmaceutical and other industries. The company operates approximately 512 drugstores; and sells its products to pharmacies, hospitals, drugstores, supermarkets, restaurants, and cafés. It exports its products to Asia, Europe, Africa, Australia, and New Zealand. PT Kimia Farma (Persero) Tbk was founded in 1817 and is headquartered in Jakarta, Indonesia.

5,332 Employees
Last Reported Date: 02/19/14
Founded in 1817

kimia farma persero tbk pt (KAEF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kimia farma persero tbk pt (KAEF) Key Developments

Kimia Farma Plans New Manufacturing Plant to Reduce Reliance on Imports

Kimia Farma has revealed that it is planning to construct a new manufacturing plant in 2015 in order to reduce its reliance on imports. The new plant will be located within Kimia's existing manufacturing complex, which is located in the regency of Jombang, East Java. The plant will be dedicated to manufacturing four active ingredients: the cholesterol-lowering drugs atorvastatin and simvastatin; the hypertension treatment amlodipine; and the antibiotic azithromycin. As was the case with that deal, the new facility will involve collaboration with external partners, with Kimia having agreed deals with unspecified Japanese and South Korean firms. Initially, the raw materials produced by the new plant will be used to meet Kimia's own needs, although there will also be scope for Kimia to act as a supplier for other companies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KAEF:IJ 1,230.00 +35.00

KAEF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KAEF.
View Industry Companies
 

Industry Analysis

KAEF

Industry Average

Valuation KAEF Industry Range
Price/Earnings 31.4x
Price/Sales 1.5x
Price/Book 4.2x
Price/Cash Flow 28.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KIMIA FARMA PERSERO TBK PT, please visit www.kimiafarma.co.id. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.